Epilepsy and sarcopenia: shared neurometabolic mechanisms and emerging brain–muscle interactions

Background Emerging evidence suggests that people with epilepsy (PWE) may be at increased risk of impaired muscle health and sarcopenia. However, the mechanisms underlying this association remain uncertain and have not been comprehensively synthesized. Methods A narrative review of clinical and preclinical literature was conducted using PubMed, Scopus, and Web of Science through March 2026. Studies addressing sarcopenia, muscle strength, physical performance, inflammation, mitochondrial dysfunction, neurotrophic signaling, nutrition, physical activity, and anti-seizure medication effects in epilepsy were evaluated. Discussion Clinical studies indicate that PWE frequently exhibit reduced handgrip strength, impaired mobility and balance performance, greater frailty, and a higher prevalence of sarcopenia than controls. Reduced physical activity and mobility limitations are among the better-supported proposed contributors, although their causal contribution to sarcopenia in PWE remains unproven. Preclinical studies and evidence derived from parallel epilepsy and sarcopenia literature further suggest potential roles for chronic inflammation, oxidative stress, mitochondrial dysfunction, altered brain-derived neurotrophic factor (BDNF) signaling, insulin resistance, nutritional deficiencies, and anti-seizure medication-related metabolic effects. However, direct evidence linking these mechanisms to muscle loss in PWE remains limited. Conclusion Current evidence supports an association between epilepsy and impaired muscle health, with physical inactivity, mobility limitations, and antiseizure medication-related effects representing the most consistently supported contributors. Several biological pathways, including inflammation, mitochondrial dysfunction, and altered neurotrophic signaling, remain plausible but incompletely validated mechanisms that require further investigation.

Authors

Institutions

Publication Details

Journal
Frontiers in Aging Neuroscience
Published
2026-11-17
DOI
https://doi.org/10.3389/fnagi.2026.1964505
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Epilepsy and sarcopenia: shared neurometabolic mechanisms and emerging brain–muscle interactions

Rizwan Qaisar, Maha Dahawi
3 links
Frontiers in Aging Neuroscience
Nutrition and Health in Aging
article

Epilepsy and sarcopenia: shared neurometabolic mechanisms and emerging brain–muscle interactions

Rizwan Qaisar, Maha Dahawi
article en

Abstract

Background Emerging evidence suggests that people with epilepsy (PWE) may be at increased risk of impaired muscle health and sarcopenia. However, the mechanisms underlying this association remain uncertain and have not been comprehensively synthesized. Methods A narrative review of clinical and preclinical literature was conducted using PubMed, Scopus, and Web of Science through March 2026. Studies addressing sarcopenia, muscle strength, physical performance, inflammation, mitochondrial dysfunction, neurotrophic signaling, nutrition, physical activity, and anti-seizure medication effects in epilepsy were evaluated. Discussion Clinical studies indicate that PWE frequently exhibit reduced handgrip strength, impaired mobility and balance performance, greater frailty, and a higher prevalence of sarcopenia than controls. Reduced physical activity and mobility limitations are among the better-supported proposed contributors, although their causal contribution to sarcopenia in PWE remains unproven. Preclinical studies and evidence derived from parallel epilepsy and sarcopenia literature further suggest potential roles for chronic inflammation, oxidative stress, mitochondrial dysfunction, altered brain-derived neurotrophic factor (BDNF) signaling, insulin resistance, nutritional deficiencies, and anti-seizure medication-related metabolic effects. However, direct evidence linking these mechanisms to muscle loss in PWE remains limited. Conclusion Current evidence supports an association between epilepsy and impaired muscle health, with physical inactivity, mobility limitations, and antiseizure medication-related effects representing the most consistently supported contributors. Several biological pathways, including inflammation, mitochondrial dysfunction, and altered neurotrophic signaling, remain plausible but incompletely validated mechanisms that require further investigation.

Frontiers in Aging NeuroscienceVol. 18
Ajman University (AE), University of Sharjah (AE)
Ajman University
Good health and well-being
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon